TransThera Sciences (Nanjing) Buys Back 217,000 H-Shares for HKD 2.24 Million, Lifting Treasury Stock to 718,000 Shares

Bulletin Express07-24

TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) disclosed that it repurchased 217,000 H-shares on 24 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 10.18 to HKD 10.72, with a volume-weighted average cost of HKD 10.3122 per share, bringing the total consideration to approximately HKD 2.24 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.07% to 311.97 million shares. Treasury shares rose to 718,000, while the total number of issued shares remained unchanged at 312.69 million.

The buyback forms part of the repurchase mandate approved on 18 June 2026, which authorises the company to repurchase up to 31.27 million shares. Cumulative repurchases under this mandate now stand at 718,000 shares, equivalent to 0.23% of the issued shares outstanding at the mandate date.

All 217,000 shares repurchased on 24 July 2026 are being held as treasury shares; no cancellations have been executed. In line with Hong Kong listing rules, TransThera Sciences is subject to a moratorium on issuing new shares or disposing of treasury shares until 23 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191390297?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-24 18:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191390297","market":"us","top_or_hot":-1,"title":"TransThera Sciences (Nanjing) Buys Back 217,000 H-Shares for HKD 2.24 Million, Lifting Treasury Stock to 718,000 Shares","media":"Bulletin Express","content":"<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) disclosed that it repurchased 217,000 H-shares on 24 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 10.18 to HKD 10.72, with a volume-weighted average cost of HKD 10.3122 per share, bringing the total consideration to approximately HKD 2.24 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.07% to 311.97 million shares. Treasury shares rose to 718,000, while the total number of issued shares remained unchanged at 312.69 million.</p>\n<p>The buyback forms part of the repurchase mandate approved on 18 June 2026, which authorises the company to repurchase up to 31.27 million shares. Cumulative repurchases under this mandate now stand at 718,000 shares, equivalent to 0.23% of the issued shares outstanding at the mandate date.</p>\n<p>All 217,000 shares repurchased on 24 July 2026 are being held as treasury shares; no cancellations have been executed. In line with Hong Kong listing rules, TransThera Sciences is subject to a moratorium on issuing new shares or disposing of treasury shares until 23 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TransThera Sciences (Nanjing) Buys Back 217,000 H-Shares for HKD 2.24 Million, Lifting Treasury Stock to 718,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTransThera Sciences (Nanjing) Buys Back 217,000 H-Shares for HKD 2.24 Million, Lifting Treasury Stock to 718,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-24 18:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) disclosed that it repurchased 217,000 H-shares on 24 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 10.18 to HKD 10.72, with a volume-weighted average cost of HKD 10.3122 per share, bringing the total consideration to approximately HKD 2.24 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.07% to 311.97 million shares. Treasury shares rose to 718,000, while the total number of issued shares remained unchanged at 312.69 million.</p>\n<p>The buyback forms part of the repurchase mandate approved on 18 June 2026, which authorises the company to repurchase up to 31.27 million shares. Cumulative repurchases under this mandate now stand at 718,000 shares, equivalent to 0.23% of the issued shares outstanding at the mandate date.</p>\n<p>All 217,000 shares repurchased on 24 July 2026 are being held as treasury shares; no cancellations have been executed. In line with Hong Kong listing rules, TransThera Sciences is subject to a moratorium on issuing new shares or disposing of treasury shares until 23 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02617","symbol_name":"药捷安康-B","start_time":0,"source_url":"","article_id":"1191390297","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191390297","pubTimestamp":1784889743,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) disclosed that it repurchased 217,000 H-shares on 24 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02617":"药捷安康-B"},"translate_title":"TransThera Sciences（南京）以224万港元回购21.7万股H股，库存股增至71.8万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02617":1},"content_text":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) disclosed that it repurchased 217,000 H-shares on 24 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 10.18 to HKD 10.72, with a volume-weighted average cost of HKD 10.3122 per share, bringing the total consideration to approximately HKD 2.24 million.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.07% to 311.97 million shares. Treasury shares rose to 718,000, while the total number of issued shares remained unchanged at 312.69 million.\nThe buyback forms part of the repurchase mandate approved on 18 June 2026, which authorises the company to repurchase up to 31.27 million shares. Cumulative repurchases under this mandate now stand at 718,000 shares, equivalent to 0.23% of the issued shares outstanding at the mandate date.\nAll 217,000 shares repurchased on 24 July 2026 are being held as treasury shares; no cancellations have been executed. In line with Hong Kong listing rules, TransThera Sciences is subject to a moratorium on issuing new shares or disposing of treasury shares until 23 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191390297","isCrawlerRequest":true}